EirGenix

EirGenix Forward P/E

The Forward P/E Ratio of EirGenix (6589.TWO) as of Oct 21, 2026 is -22.86. In the previous year, Forward P/E Ratio was -24.89 — a change of -8.18% (higher).

Forward P/E

-22.86

YoY

-8.18%

Last updated:

Forward P/E Ratio of EirGenix is 2025 -22.86 . Forward P/E Ratio of EirGenix was 2024 -24.89 . It decreases by -8.18% higher compared to the previous year.

The EirGenix Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
-47.27 TWD
Jan 1, 2019
-20.19 TWD
Jan 1, 2020
-16.69 TWD
Jan 1, 2021
-408.26 TWD
Jan 1, 2022
-150.46 TWD
Jan 1, 2023
-18.99 TWD
Jan 1, 2024
-24.89 TWD
Jan 1, 2025
-22.86 TWD
The EirGenix Forward P/E history
YEARForward P/EYoY
-22.86-8.18%
-24.89+31.05%
-18.99-87.38%
-150.46-63.15%
-408.26+2,346.33%
-16.69-17.35%
-20.19-57.28%
-47.27-52.46%
-99.42-35.71%
-154.65+19.72%
-129.18-1.23%
-130.78—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EirGenix Stock analysis

What does EirGenix do? EirGenix Inc. generates revenue through its Contract Development & Manufacturing Organization (CDMO) services, which include the construction of cell strains, manufacturing of clinical trial medicines, and analytical science and protein identification. The company operates a PIC/S manufacturing plant dedicated to producing clinical trial drugs for pharmaceutical clients. Its primary customers are pharmaceutical companies seeking outsourced development and manufacturing solutions for biotechnology drugs. The business segments focus on providing end-to-end services from research and development to clinical trial production, targeting the biotechnology and pharmaceutical sectors. EirGenix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EirGenix stock

Forward P/E Ratio of EirGenix is -22.86 in 2025.

Forward P/E Ratio of EirGenix changed from -24.89 to -22.86, representing a -8.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio EirGenix since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's EirGenix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — EirGenix

All Key Metrics — EirGenix